Artificial Transmembrane Oncoproteins Smaller than the Bovine Papillomavirus E5 Protein Redefine Sequence Requirements for Activation of the Platelet-Derived Growth Factor (cid:2) Receptor (cid:1) †

The bovine papillomavirus E5 protein (BPV E5) is a 44-amino-acid homodimeric transmembrane protein that binds directly to the transmembrane domain of the platelet-derived growth factor (PDGF) (cid:1) receptor and induces ligand-independent receptor activation. Three specific features of BPV E5 are considered important for its ability to activate the PDGF (cid:1) receptor and transform mouse fibroblasts: a pair of C-terminal cysteines, a transmembrane glutamine, and a juxtamembrane aspartic acid. By using a new genetic technique to screen libraries expressing artificial transmembrane proteins for activators of the PDGF (cid:1) receptor, we isolated much smaller proteins, from 32 to 36 residues, that lack all filtered the retroviral supernatants through 0.45- (cid:5) m filters (Millipore, Leiden, The Netherlands), and concentrated the retrovirus in Amicon ultrahigh-speed centrifugal filtration con-centrators (Millipore). We infected parental BaF3 cells with the concentrated retrovirus as follows. We infected 5 (cid:6) 10 5 BaF3 cells in 500 (cid:5) l of medium per well of a 12-well dish with 500 (cid:5) l of concentrated virus. We added polybrene at a concentration of 4 (cid:5) g/ml and incubated the mixture at 37°C for 4 h. The infected cells were then transferred to a T25 flask containing 9 ml of RPMI/IL-3 medium with polybrene. After 48 h, we added G418 at a final concentration of 1 mg/ml. We subcloned the pool of infected, G418-resistant cells by serial dilution in a 96-well plate. We expanded individual clonal lines and tested them for receptor expression, either by immunoblotting (described below) or by de- termining their ability to survive in the absence of IL-3 and the presence of PDGF-BB (Calbiochem, San Diego, CA). Clonal lines expressing the desired receptor and maintaining a strict requirement for IL-3 were used for the experiments reported here. To express small transmembrane proteins in BaF3 cell lines, we prepared retroviral particles from HEK293T cells and infected BaF3 cells with up to 500 (cid:5) l of concentrated virus, as described above. To select for infected cells, the cells were incubated in RPMI/IL-3 medium plus 1 mg/ml hygromycin. We maintained selected cells in hygromycin and G418 (where applicable) at the concentrations used for selection. C127 cells at approximately 50% confluence in a 60-mm dish were infected as follows. Filtered, concentrated virus was brought to a volume of 1 ml in DMEM10. C127 cells were infected with a 1:20 dilution of this stock in DMEM10 to a final volume of 1 ml (virus

[1]  D. DiMaio,et al.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango. , 2009, Virology.

[2]  D. DiMaio,et al.  In vitro dimerization of the bovine papillomavirus E5 protein transmembrane domain. , 2008, Biochemistry.

[3]  L. Petti,et al.  Transforming signals resulting from sustained activation of the PDGFβ receptor in mortal human fibroblasts , 2008, Journal of Cell Science.

[4]  D. DiMaio,et al.  Packing contacts can mediate highly specific interactions between artificial transmembrane proteins and the PDGFβ receptor , 2007, Proceedings of the National Academy of Sciences.

[5]  R. Lamb,et al.  The M2 Proton Channels of Influenza A and B Viruses* , 2006, Journal of Biological Chemistry.

[6]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[7]  D. DiMaio,et al.  Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein , 2005, Oncogene.

[8]  D. Engelman,et al.  Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor. , 2005, Journal of molecular biology.

[9]  Mark Gerstein,et al.  Computational analysis of membrane proteins: genomic occurrence, structure prediction and helix interactions , 2004, Quarterly Reviews of Biophysics.

[10]  M. Gerstein,et al.  Genomic analysis of membrane protein families: abundance and conserved motifs , 2002, Genome Biology.

[11]  J. Doyon,et al.  Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein , 2001, Oncogene.

[12]  R. Lamb,et al.  The SH Integral Membrane Protein of the Paramyxovirus Simian Virus 5 Is Required To Block Apoptosis in MDBK Cells , 2001, Journal of Virology.

[13]  S. Grinstein,et al.  Golgi Alkalinization by the Papillomavirus E5 Oncoprotein , 2000, The Journal of cell biology.

[14]  R. Schlegel,et al.  The Transmembrane Domain of the E5 Oncoprotein Contains Functionally Discrete Helical Faces* , 1999, The Journal of Biological Chemistry.

[15]  D. DiMaio,et al.  The Bovine Papillomavirus E5 Protein Requires a Juxtamembrane Negative Charge for Activation of the Platelet-Derived Growth Factor β Receptor and Transformation of C127 Cells , 1999, Journal of Virology.

[16]  D. Engelman,et al.  TOXCAT: a measure of transmembrane helix association in a biological membrane. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. DiMaio,et al.  Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. O. Smith,et al.  Structural models of the bovine papillomavirus E5 protein , 1998, Proteins.

[19]  T. Surti,et al.  Role of Glutamine 17 of the Bovine Papillomavirus E5 Protein in Platelet-Derived Growth Factor β Receptor Activation and Cell Transformation , 1998, Journal of Virology.

[20]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[21]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[22]  Alexander D. MacKerell,et al.  Molecular dynamics simulation of unsaturated lipid bilayers at low hydration: parameterization and comparison with diffraction studies. , 1997, Biophysical journal.

[23]  D. Drummond-Barbosa,et al.  Virocrine transformation. , 1997, Biochimica et biophysica acta.

[24]  D. Engelman,et al.  Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching , 1996, Proteins.

[25]  R. Schlegel,et al.  E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation , 1996, Journal of virology.

[26]  J. Pierce,et al.  Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein , 1995, Journal of virology.

[27]  D. DiMaio,et al.  Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells , 1995, Journal of virology.

[28]  D. DiMaio,et al.  Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling , 1995, Molecular and cellular biology.

[29]  D. DiMaio,et al.  An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein. , 1995, Oncogene.

[30]  Paul D. Adams,et al.  Computational searching and mutagenesis suggest a structure for the pentameric transmembrane domain of phospholamban , 1995, Nature Structural Biology.

[31]  S. Aaronson,et al.  The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation , 1994, Journal of virology.

[32]  D. DiMaio,et al.  Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells , 1994, Journal of virology.

[33]  A. N. Meyer,et al.  Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Lowy,et al.  Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain , 1993, Journal of virology.

[35]  D. DiMaio,et al.  Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein , 1993, Molecular and cellular biology.

[36]  R. Schlegel,et al.  The BPV‐1 E5 protein, the 16 kDa membrane pore‐forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. , 1992, The EMBO journal.

[37]  D. DiMaio,et al.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. DiMaio,et al.  The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine , 1992, Journal of virology.

[39]  D. DiMaio,et al.  Biological properties of the deer papillomavirus E5 gene in mouse C127 cells: growth transformation, induction of DNA synthesis, and activation of the platelet-derived growth factor receptor , 1991, Journal of virology.

[40]  D. DiMaio,et al.  Activation of the platelet‐derived growth factor receptor by the bovine papillomavirus E5 transforming protein. , 1991, The EMBO journal.

[41]  D. DiMaio,et al.  Transforming activity of a 16-amino-acid segment of the bovine papillomavirus E5 protein linked to random sequences of hydrophobic amino acids , 1989, Journal of virology.

[42]  D. DiMaio,et al.  44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids , 1988, Molecular and cellular biology.

[43]  Maurice Green,et al.  Demonstration that a chemically synthesized BPV1 oncoprotein and its C-terminal domain function to induce cellular DNA synthesis , 1987, Cell.

[44]  D. DiMaio,et al.  Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[46]  Brown,et al.  DNA Synthesis , 1978, NATO Advanced Study Institutes Series.